| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 10/04/2001 | EP1138784A2 Method for determining the efficiency of nucleic acid amplifications |
| 10/04/2001 | EP1138783A2 Method for the efficiency-corrected real-time quantification of nucleic acids |
| 10/04/2001 | EP1138782A2 Multiplex sequence variation analysis of DNA samples by mass spectrometry |
| 10/04/2001 | EP1138781A2 Method for Quantifying DNA binding activity of DNA binding proteins |
| 10/04/2001 | EP1138780A1 Detection of disseminated tumor cells by quantitative RT-PCR of cytokeratin 20 mRNA |
| 10/04/2001 | EP1138779A2 Methods of rapid screening of cytochrome CYP2C19 status using mephenytoin |
| 10/04/2001 | EP1138778A2 Methods of rapid screening of cytochrome CYP2C19 status using omeprazole |
| 10/04/2001 | EP1138777A2 Temperature history indicator |
| 10/04/2001 | EP1138776A1 Cell-free reconstitution of autophagocytosis |
| 10/04/2001 | EP1138771A1 Coffee endo-mannanase |
| 10/04/2001 | EP1138764A2 Two-step reverse transcription |
| 10/04/2001 | EP1138763A2 Method for generating polynucleotides having desired characteristics by iterative selection and recombination |
| 10/04/2001 | EP1138762A1 Method for immobilizing oligonucleotide on a carrier |
| 10/04/2001 | EP1138761A1 Method for immobilizing dna on a carrier |
| 10/04/2001 | EP1138689A1 N8- and C8-linked purine bases as universal nucleosides used for oligonucleotide hybridization |
| 10/04/2001 | EP1138019A2 Method and system for general purpose analysis of experimental data |
| 10/04/2001 | EP1137949A1 Assays for compounds which increase phospholipase a2 activity |
| 10/04/2001 | EP1137947A2 Method for determining asthma susceptibility |
| 10/04/2001 | EP1137945A1 Methods for detection of antiestrogen-resistant breast cancer |
| 10/04/2001 | EP1137944A2 Differential expression in primary breast cancer |
| 10/04/2001 | EP1137940A1 Assays for ligands for nuclear receptors |
| 10/04/2001 | EP1137812A1 Dna-protein fusions and uses thereof |
| 10/04/2001 | EP1137811A2 Methods of identifying point mutations in a genome |
| 10/04/2001 | EP1137810A2 A$g(b)-PEPTIDE SCREENING ASSAY |
| 10/04/2001 | EP1137809A1 Toxicity typing using embryoid bodies |
| 10/04/2001 | EP1137808A1 Methods for making recombinant cells |
| 10/04/2001 | EP1137807A1 Methods, kits and compositions for the identification of nucleic acids electrostatically bound to matrices |
| 10/04/2001 | EP1137806A1 Detection of rantes gene promoter polymorphisms |
| 10/04/2001 | EP1137805A1 Methods of facilitating vascular growth |
| 10/04/2001 | EP1137804A1 Method for detecting in vitro a target substance in a sample comprising the labelling of said substance with a reporter gene and the sequences required for expressing said reporter gene in vitro |
| 10/04/2001 | EP1137803A1 Method and kit for the characterization of antibiotic-resistance mutations in mycobacterium tuberculosis |
| 10/04/2001 | EP1137802A1 Method for determining the activity of a substance using a functional test in vitro |
| 10/04/2001 | EP1137801A1 Method for detecting and/or quantifying a known function from a nucleic acid sample |
| 10/04/2001 | EP1137800A1 Method for purifying or isolating viral nucleic acids |
| 10/04/2001 | EP1137798A1 A method of isolating stem cells |
| 10/04/2001 | EP1137792A1 A recombinant vector expressing multiple costimulatory molecules and uses thereof |
| 10/04/2001 | EP1137783A2 Beta-1,3-galactosyltransferase homologs |
| 10/04/2001 | EP1137781A1 Mutants of rna polymerases with increased stability |
| 10/04/2001 | EP1137780A1 Therapeutic and diagnostic uses of protein tyrosine phosphatase tc-ptp |
| 10/04/2001 | EP1137779A2 Identification of senv genotypes |
| 10/04/2001 | EP1137773A2 Growth factor homolog zvegf3 |
| 10/04/2001 | EP1137771A2 Methods for preventing cardiac hypertrophy and heart failure by inhibition of mef2 transcription factor |
| 10/04/2001 | EP1137769A1 T cells specific for target antigens and methods and vaccines based thereon |
| 10/04/2001 | EP1137761A1 Cutinase variants |
| 10/04/2001 | EP1137757A1 Dna molecules encoding the melanocortin 5 receptor protein from rhesus monkey |
| 10/04/2001 | EP1137754A2 Method for constructing libraries of phenotypic profiles |
| 10/04/2001 | EP1137665A1 Cark protein and nucleic acid molecules and uses therefor |
| 10/04/2001 | EP1137664A2 Protein transduction system and methods of use thereof |
| 10/04/2001 | EP1137656A1 31 human secreted proteins |
| 10/04/2001 | EP1137423A2 Oral administration of lactobacillus for the treatment and prevention of urogenital infection |
| 10/04/2001 | EP1137386A2 Use of hydroxydiphenyl ether as an antimalarial agent |
| 10/04/2001 | EP0973800A4 Novel receptor |
| 10/04/2001 | EP0924991B1 Pressure-mediated binding of biomolecular complexes |
| 10/04/2001 | EP0819249B1 Sensitive immunoassays utilizing antibody conjugates with replicable dna templates |
| 10/04/2001 | EP0796343B1 Terminal repeat amplification method |
| 10/04/2001 | EP0778945B1 Luciferase labelling method |
| 10/04/2001 | EP0772775B1 Automatic processing system for use in solid phase biospecific binding and dna sequencing techniques |
| 10/04/2001 | DE10049364A1 Kit, Verfahren und Mikroarray zur Bestimmung des Geschlechtes eines menschlichen Fötus Kit, procedures and microarray to determine the sex of a human fetus |
| 10/04/2001 | DE10045521A1 Determining amplification efficiency of a target nucleic acid comprises measuring real-time amplification of diluted series, setting signal threshold value, and determining cycle number at which threshold is exceeded |
| 10/04/2001 | DE10016348A1 Parallel sequencing of several nucleic acids, useful e.g. in gene expression analysis, using irreversibly immobilized amplification primers |
| 10/04/2001 | DE10015797A1 Multiplex-Analyse von DNA-Gemischen mittels photolytisch ablesbarer DNA-Chips Multiplex analysis of DNA mixtures by means of photolytically readable DNA chips |
| 10/04/2001 | DE10013990A1 Polyfunktionelles Trägermaterial für die komplexe Nukleinsäureanalytik Polyfunctional support material for the complex nucleic acid analysis |
| 10/04/2001 | DE10013254A1 New apparatus, useful for detecting biomolecules and polymers, comprises array of samples containing specific molecules with separate light sources and system for detecting which samples interact with molecule to be detected |
| 10/04/2001 | DE10012861A1 Rekombinante HHV8-DNA Recombinant HHV8 DNA |
| 10/04/2001 | CA2405815A1 Method for detecting and/or quantifying first molecules |
| 10/04/2001 | CA2405499A1 Methods of producing a library and methods of selecting polynucletides |
| 10/04/2001 | CA2404780A1 Targeted chromosomal genomic alterations with modified single stranded oligonucleotides |
| 10/04/2001 | CA2404663A1 A bacterial two-hybrid system for protein interaction screening |
| 10/04/2001 | CA2404660A1 Materials and methods relating to a novel splice variant of a na+ dependent glutamate transporter |
| 10/04/2001 | CA2404574A1 Isolated human g-protein coupled receptors that are members of the aminergic subfamily, nucleic acid molecules encoding human gpcr proteins, and uses thereof |
| 10/04/2001 | CA2404570A1 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof |
| 10/04/2001 | CA2404563A1 Isolated human g-protein coupled receptors of the mas proto-oncogene subfamily, nucleic acid molecules encoding human gpcr proteins, and uses thereof |
| 10/04/2001 | CA2404533A1 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof |
| 10/04/2001 | CA2404496A1 Calcium binding regulatory subunit |
| 10/04/2001 | CA2404493A1 A method for screening for autoimmune disease by identifying polymorphisms in il-12 p40 |
| 10/04/2001 | CA2404472A1 Methods for genotyping by hybridization analysis |
| 10/04/2001 | CA2404461A1 Human g-protein coupled receptors |
| 10/04/2001 | CA2404448A1 Genes involved in intestinal inflammatory diseases and use thereof |
| 10/04/2001 | CA2404432A1 Compositions and methods for identifying and targeting cancer cells |
| 10/04/2001 | CA2404428A1 High specificity marker detection |
| 10/04/2001 | CA2404421A1 Reagent systems for detecting the presence of a reduced cofactor in a sample and methods for using the same |
| 10/04/2001 | CA2404411A1 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof |
| 10/04/2001 | CA2404310A1 A p-selectin glycoprotein ligand (psgl-1) binding protein and uses therefor |
| 10/04/2001 | CA2404233A1 Compositions and methods for the therapy and diagnosis of lung cancer |
| 10/04/2001 | CA2404231A1 Methods of treating diseases with activated protein c |
| 10/04/2001 | CA2404172A1 Antiprogestins with partial agonist activity |
| 10/04/2001 | CA2404160A1 Identification of new human gaba transporter |
| 10/04/2001 | CA2404085A1 Human urothelial cell specific uroplakin transcriptional regulatory sequences, vectors comprising uroplakin-specific transcriptional regulatory sequences, and methods of use thereof |
| 10/04/2001 | CA2404041A1 Methods for increasing a cytotoxic t lymphocyte response in vivo |
| 10/04/2001 | CA2403911A1 Quality control reagents for nucleic acid microarrays |
| 10/04/2001 | CA2403909A1 Compositions and methods for the therapy and diagnosis of prostate cancer |
| 10/04/2001 | CA2403893A1 Aryl propenal double bond reductase |
| 10/04/2001 | CA2403890A1 Improved invasion assay |
| 10/04/2001 | CA2403852A1 Selectable marker genes |
| 10/04/2001 | CA2403829A1 Non-human transgenic animals expressing platelet-derived growth factor c (pdgf-c) and uses thereof |
| 10/04/2001 | CA2403800A1 Beta-like glycoprotein hormone polypeptide and heterodimer |
| 10/04/2001 | CA2403750A1 Human survivin interacting protein 1 (sip-1) |
| 10/04/2001 | CA2403646A1 Continuous process for manufacture of disposable electro-chemical sensor |
| 10/04/2001 | CA2403637A1 Novel prostate-specific or testis-specific nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods |
| 10/04/2001 | CA2403297A1 Docosahexaenoic acid as retinoid x receptor and uses thereof |